Identification of a cancer stem cell in human brain tumors
- PMID: 14522905
Identification of a cancer stem cell in human brain tumors
Abstract
Most current research on human brain tumors is focused on the molecular and cellular analysis of the bulk tumor mass. However, there is overwhelming evidence in some malignancies that the tumor clone is heterogeneous with respect to proliferation and differentiation. In human leukemia, the tumor clone is organized as a hierarchy that originates from rare leukemic stem cells that possess extensive proliferative and self-renewal potential, and are responsible for maintaining the tumor clone. We report here the identification and purification of a cancer stem cell from human brain tumors of different phenotypes that possesses a marked capacity for proliferation, self-renewal, and differentiation. The increased self-renewal capacity of the brain tumor stem cell (BTSC) was highest from the most aggressive clinical samples of medulloblastoma compared with low-grade gliomas. The BTSC was exclusively isolated with the cell fraction expressing the neural stem cell surface marker CD133. These CD133+ cells could differentiate in culture into tumor cells that phenotypically resembled the tumor from the patient. The identification of a BTSC provides a powerful tool to investigate the tumorigenic process in the central nervous system and to develop therapies targeted to the BTSC.
Similar articles
-
Cancer stem cells in nervous system tumors.Oncogene. 2004 Sep 20;23(43):7267-73. doi: 10.1038/sj.onc.1207946. Oncogene. 2004. PMID: 15378086 Review.
-
Prospective identification of tumorigenic prostate cancer stem cells.Cancer Res. 2005 Dec 1;65(23):10946-51. doi: 10.1158/0008-5472.CAN-05-2018. Cancer Res. 2005. PMID: 16322242
-
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.Stem Cells. 2009 Aug;27(8):1722-33. doi: 10.1002/stem.98. Stem Cells. 2009. PMID: 19544433
-
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304. BMC Cancer. 2008. PMID: 18940013 Free PMC article.
-
Glioblastoma and stem cells.Neoplasma. 2008;55(5):369-74. Neoplasma. 2008. PMID: 18665745 Review.
Cited by
-
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.Neuro Oncol. 2016 Feb;18(2):227-35. doi: 10.1093/neuonc/nov123. Epub 2015 Jul 16. Neuro Oncol. 2016. PMID: 26188016 Free PMC article.
-
Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro.Clin Exp Metastasis. 2013 Dec;30(8):1009-18. doi: 10.1007/s10585-013-9599-0. Epub 2013 Jul 6. Clin Exp Metastasis. 2013. PMID: 23832741
-
Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.Cancer Biol Ther. 2012 Dec;13(14):1396-406. doi: 10.4161/cbt.22000. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954703 Free PMC article.
-
Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.Acta Pharmacol Sin. 2013 Jun;34(6):793-804. doi: 10.1038/aps.2013.56. Acta Pharmacol Sin. 2013. PMID: 23736004 Free PMC article.
-
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.Cancer Immunol Immunother. 2013 Jan;62(1):125-35. doi: 10.1007/s00262-012-1319-0. Epub 2012 Jul 31. Cancer Immunol Immunother. 2013. PMID: 22847020 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials